Maiken Joergensen


Affiliation: Odense University Hospital
Country: Denmark


  1. Joergensen M, Heegaard N, Schaffalitzky de Muckadell O. Comparison of plasma Tu-M2-PK and CA19-9 in pancreatic cancer. Pancreas. 2010;39:243-7 pubmed publisher
    ..Tu-M2-PK was inferior to CA19-9 as marker of PDAC. Tu-M2-PK may have a role in diagnosing PDAC because it is not affected by cholestasis or Lewis phenotype. Neither tumor marker can stand alone in the diagnosis of PDAC. ..
  2. Joergensen M, Brunner N, de Muckadell O. Comparison of circulating MMP-9, TIMP-1 and CA19-9 in the detection of pancreatic cancer. Anticancer Res. 2010;30:587-92 pubmed
    ..Circulating MMP-9 and TIMP-1 were inferior to CA19-9 as markers for detecting pancreatic ductal adenocarcinoma and did not improve the diagnostic accuracy when combined with CA19-9. ..
  3. Joergensen M, Brusgaard K, Crüger D, Gerdes A, Schaffalitzky de Muckadell O. Genetic, epidemiological, and clinical aspects of hereditary pancreatitis: a population-based cohort study in Denmark. Am J Gastroenterol. 2010;105:1876-83 pubmed publisher
    ..Genetic testing thus helps to predict the prognosis of the pancreatitis. ..